Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,084.00    0.00 (0.00%)
Bid:
3,000.00
Ask:
3,390.00
Spread: 390.00 (13.00%)
Market Cap: £4.30b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Directorate Change

5 Mar 2015 07:00

RNS Number : 5249G
Croda International PLC
05 March 2015
 

5th March 2015

 

 

Croda International Plc

 

Appointment of Chairman Designate

 

Croda International Plc ('Croda or 'the Company') today announces that it has appointed Anita Frew as a Non-Executive Director and Chairman Designate. Anita will join the Board with immediate effect and will succeed Martin Flower as Chairman in September. Martin will then retire from the Board after ten years as Croda's Chairman.

 

Anita has held board positions with both FTSE 100 and FTSE 250 companies across a range of sectors for the past eighteen years. She was on the board of Victrex plc, the speciality chemicals company, for fourteen years, including six years as Chairman. She is currently Deputy Chairman of Lloyds Banking Group PLC and Senior Independent Director of IMI plc.

 

On joining the Board, Anita will be appointed to the Nomination and Remuneration Committees and succeed Martin Flower as Chairman of the Nominations Committee in September 2015.

 

Martin Flower, Chairman, said:

 

"Anita's depth of boardroom experience and strong understanding of the speciality chemicals sector will be of enormous benefit to Croda. I am delighted to be handing over the reins to someone with such impeccable credentials. I am very pleased to welcome Anita to the Board and look forward to working closely with her over the coming months."

 

Anita Frew said:

 

"I feel tremendous affinity with Croda given the Group's strong focus on innovation, R&D and new product development for its global customer base. It is an exceptionally well managed and invested business and I look forward to working with the senior team and building on the good growth momentum that has been achieved in 2014."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

-ENDS-

 

Enquiries:

 

Croda International PlcMartin Flower, ChairmanNigel Turner, Senior Independent Director

Steve Foots, Chief Executive

 

+ 44 (0) 1405 860 551

Pendomer Charles Armitstead

 

+44 (0) 20 3603 5220

 

Notes to Editors

 

Anita Frew's former appointments have included: Chairman of Victrex plc, having previously been its Senior Independent Director; Senior Independent Director of Aberdeen Asset Management; Executive Director of Abbott Mead Vickers; Director of Corporate Development at WPP Group and Non-Executive Director of Northumbrian Water. She has held various investment and marketing roles at Scottish Provident and the Royal Bank of Scotland.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGMGGFZDGGKZM
Date   Source Headline
11th Jun 20262:58 pmRNSDirector/PDMR Shareholding
11th Jun 20269:15 amRNSDirector Declaration
1st Jun 20261:46 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSDirector/PDMR Shareholding
29th May 20263:10 pmRNSDirector/PDMR Shareholding
29th May 20261:53 pmRNSDirector/PDMR Shareholding
29th May 20261:52 pmRNSDirector/PDMR Shareholding
29th May 20261:45 pmRNSDirector/PDMR Shareholding
15th May 20269:23 amRNSDirector/PDMR Shareholding
12th May 202612:10 pmRNSDirector/PDMR Shareholding
6th May 20261:21 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:20 amRNSResult of AGM
22nd Apr 20267:00 amRNSFirst quarter 2026 sales in line with expectations
13th Apr 20261:41 pmRNSDirector/PDMR Shareholding
31st Mar 202611:48 amRNSHolding(s) in Company
26th Mar 20264:34 pmRNSDirector/PDMR Shareholding
18th Mar 20263:31 pmRNSDirector/PDMR Shareholding
18th Mar 20263:30 pmRNSDirector/PDMR Shareholding
18th Mar 20263:27 pmRNSDirector/PDMR Shareholding
18th Mar 20263:25 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:20 pmRNSDirector/PDMR Shareholding
16th Mar 20261:36 pmRNSAnnual Financial Report
16th Mar 20261:36 pmRNSAnnual Financial Report
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
6th Mar 20261:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:13 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSResults for the year ended 31 December 2025
11th Feb 20262:59 pmRNSDirector/PDMR Shareholding
13th Jan 20262:47 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSDirector Declaration
11th Dec 202511:30 amRNSDirector/PDMR Shareholding
11th Nov 202511:19 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSThird quarter 2025 sales update
14th Oct 20251:58 pmRNSDirector/PDMR Shareholding
8th Oct 20254:26 pmRNSDirector/PDMR Shareholding
1st Oct 20253:45 pmRNSDirector/PDMR Shareholding
18th Sep 20253:49 pmRNSHolding(s) in Company
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
11th Sep 20253:54 pmRNSDirector/PDMR Shareholding
29th Aug 20253:58 pmRNSHolding(s) in Company
29th Aug 202511:03 amRNSHolding(s) in Company
27th Aug 20251:58 pmRNSHolding(s) in Company
22nd Aug 20254:24 pmRNSDirector/PDMR Shareholding
22nd Aug 202511:55 amRNSDirector/PDMR Shareholding
14th Aug 20259:10 amRNSDirector/PDMR Shareholding
12th Aug 202511:42 amRNSDirector/PDMR Shareholding
7th Aug 20259:16 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.